Sort

Search

01/03/2023 Clinical and endoscopic outcomes of patients with colonic Crohn's disease treated with 5-aminosalicylates as monotherapy
Castillo-Regalado E., Ríos R., Aràjol C., Gely C., Márquez L., Calafat M., González-Muñoza C., Cañete F., Mesonero F., Guardiola J., Garcia-Planella E., Mañosa M., Domènech E.. Clinical and endoscopic outcomes of patients with colonic Crohn's disease treated with 5-aminosalicylates as monotherapy. Gastroenterologia y Hepatologia. 2023; 46(3)DOI:10.1016/j.gastrohep.2022.09.003. PMID:36179946. IF:2.200(Q3/6D).
28/02/2023 Possible role for rare TRPM7 variants in patients with hypomagnesaemia with secondary hypocalcaemia
Vargas-Poussou, R, Claverie-Martin, F, Prot-Bertoye, C, Carotti, V, van der Wijst, J, Perdomo-Ramirez, A, Fraga-Rodriguez, GM, Hureaux, M, Bos, C, Latta, F, Houillier, P, Hoenderop, JGJ, de Baaij, JHF. Possible role for rare TRPM7 variants in patients with hypomagnesaemia with secondary hypocalcaemia. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023; 38(3)DOI:10.1093/ndt/gfac182. PMID:35561741. IF:4.800(Q1/2D).
28/02/2023 Prediction of outcomes in subjects with type 2 diabetes and diabetic foot ulcers in Catalonian primary care centers: a multicenter observational study
Bundo, M, Vlacho, B, Llussa, J, Bobe, I, Aivar, M, Ciria, C, Martinez-Sanchez, A, Real, J, Mata-Cases, M, Cos, X, Doria, M, Viade, J, Franch-Nadal, J, Mauricio, D. Prediction of outcomes in subjects with type 2 diabetes and diabetic foot ulcers in Catalonian primary care centers: a multicenter observational study. Journal of Foot and Ankle Research. 2023; 16(1)DOI:10.1186/s13047-023-00602-6. PMID:36849888. IF:2.500(Q1/3D).
27/02/2023 Last twenty-years activity of cardiovascular tissue banking in Barcelona
Castells-Sala C., Pérez M.L., Agustí E., Aiti A., Tarragona E., Navarro A., Tabera J., Farinas, O, Pomar J.L., Vilarrodona A.. Last twenty-years activity of cardiovascular tissue banking in Barcelona. CELL AND TISSUE BANKING. 2023; DOI:10.1007/s10561-022-10059-9. PMID:36849631. IF:1.400(Q4/9D).
27/02/2023 Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer
Chmielecki, J, Gray, JE, Cheng, Y, Ohe, Y, Imamura, F, Cho, BC, Lin, MC, Majem, M, Shah, R, Rukazenkov, Y, Todd, A, Markovets, A, Barrett, JC, Hartmaier, RJ, Ramalingam, SS. Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. Nature Communications. 2023; 14(1)DOI:10.1038/s41467-023-35961-y. PMID:36849494. IF:14.700(Q1/1D).
27/02/2023 Percutaneous transhepatic biliary drainage for biliary obstruction in perihilar cholangiocarcinoma: a 10-year analysis of safety and outcomes using the CCI index
Paez-Carpio, A, Hessheimer, A, Bermudez, P, Zarco, FX, Serrano, E, Moreno, J, Molina, V, Ausania, F, Carrero, E, Burrel, M, Fondevila, C, Gomez, FM. Percutaneous transhepatic biliary drainage for biliary obstruction in perihilar cholangiocarcinoma: a 10-year analysis of safety and outcomes using the CCI index. LANGENBECKS ARCHIVES OF SURGERY. 2023; 408(1)DOI:10.1007/s00423-023-02852-1. PMID:36847837. IF:2.100(Q2/4D).
26/02/2023 Cardiovascular disease in women: Do we need new diagnostic and therapeutic strategies?
Jiménez-Quevedo P., Alonso-Martin C., Ruiz R.C., Guzmán-Martinez G., Perez M.P., Sambola A.. Cardiovascular disease in women: Do we need new diagnostic and therapeutic strategies?. POLISH HEART JOURNAL-KARDIOLOGIA POLSKA. 2023; 81(4)DOI:10.33963/KP.a2023.0051. PMID:36871309. IF:3.700(Q1/3D).
26/02/2023 A 37-Year-Old Man with Familial Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations Presenting with Seizures and a Diagnosis of Brain Abscesses
Hernández-de Sosa N., Cardona Corrales R., Casademont J.. A 37-Year-Old Man with Familial Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations Presenting with Seizures and a Diagnosis of Brain Abscesses. AMERICAN JOURNAL OF CASE REPORTS. 2023; 24DOI:10.12659/AJCR.938548. PMID:36841939. IF:(Q/D).
23/02/2023 Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection
Sadowski, C, Belknap, R, Holland, DP, Moro, RN, Chen, MP, Wright, A, Millet, JP, Cayla, JA, Scott, NA, Borisov, A, Gandhi, NR. Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection. CLINICAL INFECTIOUS DISEASES. 2023; 76(12)DOI:10.1093/cid/ciad083. PMID:36815322. IF:8.200(Q1/1D).
23/02/2023 Severe community-acquired Streptococcus pneumoniae bacterial meningitis: clinical and prognostic picture from the intensive care unit
Martin-Cerezuela, M, Aseginolaza-Lizarazu, M, Boronat-Garcia, P, Asensio-Martin, MJ, Alaman-Laguarda, G, Alvarez-Lerma, F, Roa-Alonso, D, Socias, L, Vera-Artazcoz, P, Ramirez-Galleymore, P. Severe community-acquired Streptococcus pneumoniae bacterial meningitis: clinical and prognostic picture from the intensive care unit. CRITICAL CARE. 2023; 27(1)DOI:10.1186/s13054-023-04347-3. PMID:36823625. IF:8.800(Q1/1D).
23/02/2023 Effectiveness of a Road Traffic Injury Prevention Intervention in Reducing Pedestrian Injuries, Barcelona, Spain, 2002-2019
Pérez K., Santamariña-Rubio E., Ferrando J., López M.J., Badiella L.. Effectiveness of a Road Traffic Injury Prevention Intervention in Reducing Pedestrian Injuries, Barcelona, Spain, 2002-2019. AMERICAN JOURNAL OF PUBLIC HEALTH. 2023; 113(5)DOI:10.2105/AJPH.2022.307216. PMID:36821808. IF:9.700(Q1/1D).
22/02/2023 Non-muscle-invasive (Ta, T1 and Cis) bladder cancer
BABJUK, MARKO, Palou J., ROUPRET, MORGAN. Non-muscle-invasive (Ta, T1 and Cis) bladder cancer. European Association of Urology Guidelines. 2023; DOI:. PMID:. IF:(Q/D).
22/02/2023 Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials
Kokolakis, G, Warren, RB, Strober, B, Blauvelt, A, Puig, L, Morita, A, Gooderham, M, Korber, A, Vanvoorden, V, Wang, M, de Cuyper, D, Madden, C, Gomez, NN, Lebwohl, M. Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials. BRITISH JOURNAL OF DERMATOLOGY. 2023; 188(3)DOI:10.1093/bjd/ljac089. PMID:36751950. IF:11.000(Q1/1D).
20/02/2023 Effectiveness of four deconstructive meditative practices on well-being and self-deconstruction: study protocol for an exploratory randomized controlled trial
García-Campayo J., Hijar-Aguinaga R., López-Del-Hoyo Y., Magallón-Botaya R., Fernández-Martínez S., Barceló-Soler A., Soler-Ribaudi J., Montero-Marin J.. Effectiveness of four deconstructive meditative practices on well-being and self-deconstruction: study protocol for an exploratory randomized controlled trial. Trials. 2023; 24(1)DOI:10.1186/s13063-023-07151-0. PMID:36805694. IF:2.000(Q3/7D).
20/02/2023 Expanded hemodialysis: what's up, Doc?
Garcia-Prieto, A, de la Flor, JC, Coll, E, Iglesias, E, Reque, J, Valga, F. Expanded hemodialysis: what's up, Doc?. Clinical Kidney Journal. 2023; 16(7)DOI:10.1093/ckj/sfad033. PMID:37398691. IF:3.900(Q1/2D).
19/02/2023 Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by 18F-FDG PET in patients with a recent ischemic stroke
Garcia E., Camps-Renom P., Puig N., Fernández-Leon A., Aguilera-Simón A., Benitez-Amaro A., Solé A., Vilades D., Sanchez-Quesada J.L., Martí-Fàbregas J., Jiménez-Xarrié E., Benitez S., Llorente-Cortés V.. Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by 18F-FDG PET in patients with a recent ischemic stroke. Journal of Translational Medicine. 2023; 21(1)DOI:10.1186/s12967-022-03867-w. PMID:36805772. IF:6.100(Q1/2D).
17/02/2023 A City Surveillance System for Social Health Inequalities: The Case of Barcelona
Borrell C., Palència L., Marí-Dell’Olmo M., Bartoll X., Gotsens M., Pasarín M.I., Artazcoz L., Rodríguez-Sanz M., López M.J., Pérez K.. A City Surveillance System for Social Health Inequalities: The Case of Barcelona. International Journal of Environmental Research and Public Health. 2023; 20(4)DOI:10.3390/ijerph20043536. PMID:36834231. IF:(Q/D).
15/02/2023 Glucocorticoid-based pharmacotherapies preventing PTSD
Florido, A, Velasco, ER, Monari, S, Cano, M, Cardoner, N, Sandi, C, Andero, R, Perez-Caballero, L. Glucocorticoid-based pharmacotherapies preventing PTSD. NEUROPHARMACOLOGY. 2023; 224DOI:10.1016/j.neuropharm.2022.109344. PMID:36402246. IF:4.600(Q1/2D).
15/02/2023 Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease
Shi L., Xu J., Green R., Wretlind A., Homann J., Buckley N.J., Tijms B.M., Vos S.J.B., Lill C.M., Kate M.T., Engelborghs S., Sleegers K., Frisoni G.B., Wallin A., Lleó A., Popp J., Martinez-Lage P., Streffer J., Barkhof F., Zetterberg H., Visser P.J., Lovestone S., Bertram L., Nevado-Holgado A.J., Proitsi P., Legido-Quigley C.. Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease. ALZHEIMERS & DEMENTIA. 2023; 19(8)DOI:10.1002/alz.12961. PMID:36790009. IF:13.100(Q1/1D).
14/02/2023 Corrigendum to “SELNET clinical practice guidelines for soft tissue sarcoma and GIST” [Cancer Treat. Rev. 102 (2021) 102312] (Cancer Treatment Reviews (2022) 102, (S0305737221001602), (10.1016/j.ctrv.2021.102312))
Blay J.Y., Hindi N., Bollard J., Aguiar S., Jr., Angel M., Araya B., Badilla R., Bernabeu D., Campos F., Caro-Sánchez C.H.S., Carvajal B., Carvajal Montoya A., Casavilca-Zambrano S., Castro-Oliden V., Chacón M., Clara M., Collini P., Correa Genoroso R., Costa F.D., Cuellar M., dei Tos A.P., Dominguez Malagon H.R., Donati D., Dufresne A., Eriksson M., Farias-Loza M., Fernandez P., Frezza A.M., Frisoni T., Garcia-Ortega D.Y., Gelderblom H., Gouin F., Gómez-Mateo M.C., Gronchi A., Haro J., Huanca L., Jimenez N., Karanian M., Kasper B., Lopes David B.B., Lopez-Pousa A., Lutter G., Martinez-Said H., Martinez-Tlahuel J., Mello C.A., Morales Pérez J.M., Moura David S., Nascimento A.G., Ortiz-Cruz E.J., Palmerini E., Patel S., Pfluger Y., Provenzano S., Righi A., Rodriguez A., Salas R., Santos T.T.G., Scotlandi K., Soule T., Stacchiotti S., Valverde C., Waisberg F., Zamora Estrada E., Martin-Broto J.. Corrigendum to “SELNET clinical practice guidelines for soft tissue sarcoma and GIST” [Cancer Treat. Rev. 102 (2021) 102312] (Cancer Treatment Reviews (2022) 102, (S0305737221001602), (10.1016/j.ctrv.2021.102312)). CANCER TREATMENT REVIEWS. 2023; 115DOI:10.1016/j.ctrv.2023.102523. PMID:36796283. IF:9.600(Q1/1D).